Regarding cell therapy, both pre-clinical [42,43,44] and clinical [45,46] trials have proven to successfully correct Haemophilia A phenotype by means of lentiviral and adeno-associated vector-mediated expression of FVIII in adult stem cells, autologous fibroblasts, platelets, or hematopoietic stem cells. Here, F8 is linked to hemophilia A.